Thiazolopyrimidines and their use as inhibitors of phosphatidylinositol-3 kinase
US8168633B2 · kind B2 · utility
5Cited by
6References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 7, 2011 |
| Grant date | May 1, 2012 |
| Priority date | — |
| Expiry date | Jan 7, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Thiazolopyrimidine compounds of formula I, where W represents a thiazole ring, selectively inhibit the p110 delta subtype of PI3 Kinase (PI3K), and are useful for treating diseases and disorders arising from abnormal cell growth, function or behavior associated with PI3 kinase such as cancer, immune disorders, cardiovascular disease, viral infection, inflammation, metabolism/endocrine function disorders and neurological disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.